Ligand acceptor

Please wait a moment until all data is loaded. This message will disappear when all data is loaded.

Basic Ligand Information

Molecular Structure

acceptor

Synonyms:

alpha-(1,4) glucan, alpha-1,4-glucan, alpha-glucan, an [amino-group carrier protein mutant E42R]-C-terminal-gamma-(L-glutamyl)-L-glutamate, base1, base2, halide, HX

Related pathways

BRENDA

3-phenylpropionate degradation, alanine metabolism, arachidonic acid metabolism, C30 carotenoid biosynthesis, carotenoid biosynthesis

more

MetaCyc

(4R)-carveol and (4R)-dihydrocarveol degradation, (4S)-carveol and (4S)-dihydrocarveol degradation, (5R)-carbapenem carboxylate biosynthesis, (aminomethyl)phosphonate degradation, (R)-camphor degradation, (S)-camphor degradation, 10,13-epoxy-11-methyl-octadecadienoate biosynthesis, 15-epi-lipoxin biosynthesis, 2,2'-bis-(4-hydroxy-3-methybut-2-enyl)-beta,beta-carotene monoglucoside biosynthesis, 2,4,6-trinitrotoluene degradation, 2,4-xylenol degradation to protocatechuate, 2-keto-L-gulonate biosynthesis, 3,4-dichlorobenzoate degradation, 3-chlorobenzoate degradation II (via protocatechuate), 3-methylquinoline degradation, 3-phenylpropanoate degradation, 4,4'-diapolycopenedioate biosynthesis, 4-aminobenzoate biosynthesis III, 4-ethylphenol degradation (anaerobic), 4-nitrotoluene degradation II, 5,6-dimethylbenzimidazole biosynthesis II (anaerobic), 5-deoxystrigol biosynthesis, 5-hydroxybenzimidazole biosynthesis (anaerobic), 5-hydroxymethylfurfural degradation, 5-methoxy-6-methylbenzimidazole biosynthesis (anaerobic), 5-methoxybenzimidazole biosynthesis (anaerobic), 6-diazo-5-oxo-L-norleucine biosynthesis, 6-methoxypodophyllotoxin biosynthesis, 7,8-dimethylmenaquinone biosynthesis, abscisic acid biosynthesis shunt, abscisic acid degradation to phaseic acid, actinorhodin biosynthesis, adlupulone and adhumulone biosynthesis, alliin metabolism, alpha-cyclopiazonate biosynthesis, alpha-tomatine biosynthesis, Amaryllidacea alkaloids biosynthesis, ammonia oxidation I (aerobic), ammonia oxidation III, anandamide lipoxygenation, anditomin biosynthesis, androstenedione degradation I (aerobic), androstenedione degradation II (anaerobic), arachidonate metabolites biosynthesis, arginomycin biosynthesis, aromatic biogenic amine degradation (bacteria), arsenate reduction (respiratory), arsonoacetate degradation, ascorbate recycling (cytosolic), aspirin triggered resolvin D biosynthesis, aspirin triggered resolvin E biosynthesis, aspoquinolone biosynthesis, astaxanthin biosynthesis (bacteria, fungi, algae), astaxanthin biosynthesis (flowering plants), atrazine degradation II, aureothin biosynthesis, aurone biosynthesis, bacilysin biosynthesis, bacterioruberin biosynthesis, benzene degradation IV (anaerobic), beta-carboline biosynthesis, beta-dihydromenaquinone-9 biosynthesis, beta-pyrazole-1-ylalanine biosynthesis, betacyanin biosynthesis (via dopamine), bile acid biosynthesis, neutral pathway, bis(guanylyl molybdopterin) cofactor sulfurylation, bisucaberin biosynthesis, blasticidin S biosynthesis, bombykol biosynthesis, brassinolide biosynthesis I, brassinolide biosynthesis II, brassinosteroids inactivation, bupropion degradation, butachlor degradation, C20 prostanoid biosynthesis, calendate biosynthesis, canavanine biosynthesis, candicidin biosynthesis, cannabinoid biosynthesis, canthaxanthin biosynthesis, carbofuran degradation I, carbofuran degradation II, carbon tetrachloride degradation I, carbon tetrachloride degradation II, carnosate bioynthesis, cephamycin C biosynthesis, chanoclavine I aldehyde biosynthesis, chaxamycin biosynthesis, chitin degradation II (Vibrio), chitin degradation III (Serratia), chloramphenicol biosynthesis, chlorate reduction, chlorobactene biosynthesis, cholesterol degradation to androstenedione I (cholesterol oxidase), cholesterol degradation to androstenedione II (cholesterol dehydrogenase), cholesterol degradation to androstenedione III (anaerobic), choline degradation I, cinchona alkaloids biosynthesis, cis-geranyl-CoA degradation, cis-zeatin biosynthesis, citronellol degradation, cob(II)yrinate a,c-diamide biosynthesis I (early cobalt insertion), coelimycin P1 biosynthesis, coenzyme B biosynthesis, coenzyme M biosynthesis I, coenzyme M biosynthesis II, colibactin biosynthesis, colupulone and cohumulone biosynthesis, creatinine degradation III, crocetin biosynthesis, cuticular wax biosynthesis, cyclohexane-1-carboxyl-CoA biosynthesis, cyclooctatin biosynthesis, cytidylyl molybdenum cofactor sulfurylation, cytochrome c biogenesis (system I type), D-arginine degradation, D-xylose degradation IV, decaprenoxanthin diglucoside biosynthesis, dehydroabietic acid biosynthesis, desferrioxamine B biosynthesis, desferrioxamine E biosynthesis, di-homo-gamma-linolenate metabolites biosynthesis, diadinoxanthin and fucoxanthin biosynthesis, diazepinomicin biosynthesis, dimethylsulfoniopropanoate biosynthesis III (algae and phytoplankton), dimorphecolate biosynthesis, docosahexaenoate biosynthesis I (lower eukaryotes), docosahexaenoate biosynthesis III (6-desaturase, mammals), docosahexaenoate biosynthesis IV (4-desaturase, mammals), docosahexaenoate metabolites biosynthesis, dTDP-beta-L-evernitrose biosynthesis, dTDP-D-desosamine biosynthesis, ecdysone and 20-hydroxyecdysone biosynthesis, ellagic acid degradation to urolithins, Entner-Doudoroff pathway II (non-phosphorylative), ergotamine biosynthesis, ergothioneine biosynthesis I (bacteria), ergothioneine biosynthesis II (fungi), ethylbenzene degradation (anaerobic), eumelanin biosynthesis, factor 430 biosynthesis, fatty acid alpha-oxidation I (plants), firefly bioluminescence, flexixanthin biosynthesis, fosfomycin biosynthesis, FR-900098 and FR-33289 antibiotics biosynthesis, furfural degradation, gamma-coniciene and coniine biosynthesis, gentamicin biosynthesis, gibberellin biosynthesis IV (Gibberella fujikuroi), gibberellin biosynthesis V, ginkgotoxin biosynthesis, glucose degradation (oxidative), glucosinolate biosynthesis from dihomomethionine, glutathione amide metabolism, glutathione-mediated detoxification I, glutathione-mediated detoxification II, glycine betaine biosynthesis I (Gram-negative bacteria), glycolipid desaturation, glyphosate degradation III, heliocides biosynthesis, heme a biosynthesis, heme b biosynthesis III (from siroheme), heme d1 biosynthesis, heme degradation III, heme degradation IV, heme degradation VI, heme degradation VII, hispidol and hispidol 4'-O-beta-D-glucoside biosynthesis, holomycin biosynthesis, hopanoid biosynthesis (bacteria), hydrogen oxidation I (aerobic), hypericin biosynthesis, hypoglycin biosynthesis, hypusine biosynthesis, icosapentaenoate biosynthesis I (lower eukaryotes), icosapentaenoate biosynthesis II (6-desaturase, mammals), icosapentaenoate metabolites biosynthesis, indole glucosinolate activation (herbivore attack), indole-3-acetate biosynthesis II, indole-3-acetate degradation II, indole-3-acetate inactivation I, indole-3-acetate inactivation II, indole-3-acetate inactivation IV, indole-3-acetate inactivation VII, isethionate degradation, isoprene degradation, isorenieratene biosynthesis I (actinobacteria), isorenieratene biosynthesis II (Chlorobiaceae), juglone biosynthesis, K-252 biosynthesis, L-arabinose degradation IV, L-arginine degradation XII, L-ascorbate biosynthesis III (D-sorbitol pathway), L-ascorbate biosynthesis V (euglena, D-galacturonate pathway), L-ascorbate biosynthesis VIII (engineered pathway), L-ascorbate degradation V, L-asparagine degradation II, L-cysteine biosynthesis V (mycobacteria), L-dopa degradation II (bacterial), L-histidine degradation VI, L-lysine degradation V, L-tryptophan degradation V (side chain pathway), L-tryptophan degradation XI (mammalian, via kynurenine), labdane-type diterpenes biosynthesis, lactucaxanthin biosynthesis, leinamycin biosynthesis, limonene degradation IV (anaerobic), linoleate metabolites biosynthesis, lipoxin biosynthesis, lupulone and humulone biosynthesis, lycopadiene biosynthesis, m-xylene degradation (anaerobic), malbrancheamide biosynthesis, mandelate degradation I, melatonin degradation II, methylamine degradation II, methylarsonous acid detoxification III, methylphosphonate degradation I, methylphosphonate degradation II, mitomycin biosynthesis, molybdenum cofactor sulfulylation (eukaryotes), molybdopterin biosynthesis, mycofactocin biosynthesis, mycolate biosynthesis, myxol-2' fucoside biosynthesis, naphthalene degradation (anaerobic), naphthomycin biosynthesis, neurosporaxanthin biosynthesis, neurosporene biosynthesis, nicotinate degradation II, nicotine degradation I (pyridine pathway), nicotine degradation II (pyrrolidine pathway), nicotine degradation IV, nicotine degradation V, NiFe(CO)(CN)2 cofactor biosynthesis, nitrilotriacetate degradation, nopaline degradation, octane oxidation, octopine degradation, okenone biosynthesis, oligomeric urushiol biosynthesis, papaverine biosynthesis, penigequinolone biosynthesis, perchlorate reduction, phenylethylamine degradation II, phenylphenalenone biosynthesis, phosalacine biosynthesis, phosphinothricin tripeptide biosynthesis, phylloquinol biosynthesis, picolinate degradation, pinoresinol degradation, plasmalogen biosynthesis II (anaerobic), platensimycin biosynthesis, polyacyltrehalose biosynthesis, protein SAMPylation and SAMP-mediated thiolation, purine nucleobases degradation I (anaerobic), pyoverdine I biosynthesis, pyrrolnitrin biosynthesis, pyrroloquinoline quinone biosynthesis, pyruvate fermentation to (R)-acetoin I, pyruvate fermentation to (S)-acetoin, queuosine biosynthesis I (de novo), queuosine biosynthesis III (queuosine salvage), quinoxaline-2-carboxylate biosynthesis, rifamycin B biosynthesis, roseoflavin biosynthesis, rotenoid biosynthesis I, rotenoid biosynthesis II, roxarsone (and nitarsone) degradation III, roxarsone degradation I, salicin biosynthesis, salicortin biosynthesis, saliniketal A biosynthesis, salinosporamide A biosynthesis, sarcinaxanthin diglucoside biosynthesis, seleno-amino acid detoxification and volatilization II, seleno-amino acid detoxification and volatilization III, sesaminol glucoside biosynthesis, sesquiterpenoid phytoalexins biosynthesis, shikonin biosynthesis, sitosterol degradation to androstenedione, solasodine and soladulcidine biosynthesis, sorgoleone biosynthesis, spectinabilin biosynthesis, spheroidene and spheroidenone biosynthesis, spirilloxanthin and 2,2'-diketo-spirilloxanthin biosynthesis, staphyloxanthin biosynthesis, staurosporine biosynthesis, sterculate biosynthesis, sterigmatocystin biosynthesis, streptomycin biosynthesis, streptorubin B biosynthesis, streptovaricin biosynthesis, streptozotocin biosynthesis, sulfolactate degradation II, sulfolactate degradation III, sulfur oxidation IV (intracellular sulfur), superpathway of phylloquinol biosynthesis, superpathway of sulfide oxidation (Acidithiobacillus ferrooxidans), synechoxanthin biosynthesis, taurine degradation II, terminal olefins biosynthesis II, terrequinone A biosynthesis, testosterone and androsterone degradation to androstendione (aerobic), testosterone degradation (anaerobic), tetrachloroethene degradation, tetrahydromethanopterin biosynthesis, tetrathionate reduction I (to thiosulfate), thiamine phosphate formation from pyrithiamine and oxythiamine (yeast), thiazole component of thiamine diphosphate biosynthesis II, thioredoxin pathway, thiosulfate oxidation II (via tetrathionate), thyroid hormone metabolism I (via deiodination), thyroid hormone metabolism II (via conjugation and/or degradation), thyronamine and iodothyronamine metabolism, trans-4-hydroxy-L-proline degradation II, trans-lycopene biosynthesis I, trans-zeatin biosynthesis, tRNA-uridine 2-thiolation (cytoplasmic), tRNA-uridine 2-thiolation (mammalian mitochondria), tRNA-uridine 2-thiolation (thermophilic bacteria), tRNA-uridine 2-thiolation (yeast mitochondria), tRNA-uridine 2-thiolation and selenation (bacteria), ubiquinol-10 biosynthesis (early decarboxylation), ubiquinol-10 biosynthesis (late decarboxylation), ubiquinol-6 biosynthesis (late decarboxylation), ubiquinol-6 biosynthesis from 4-aminobenzoate (yeast), ubiquinol-7 biosynthesis (early decarboxylation), ubiquinol-7 biosynthesis (late decarboxylation), ubiquinol-8 biosynthesis (early decarboxylation), ubiquinol-8 biosynthesis (late decarboxylation), ubiquinol-9 biosynthesis (early decarboxylation), ubiquinol-9 biosynthesis (late decarboxylation), uracil degradation II (oxidative), urate conversion to allantoin III, validamycin biosynthesis, vindoline, vindorosine and vinblastine biosynthesis, vitamin B6 degradation I, vitamin B6 degradation II, xanthommatin biosynthesis, zealexin biosynthesis

more

Show all BRENDA pathways known for acceptor

close all tables

open all tables

Roles as Enzyme Ligand

In Vivo Substrate in Enzyme-catalyzed Reactions (204 results)

top print hide

1.1.1.14

D-sorbitol + acceptor = L-sorbose + reduced acceptor

740006

1.1.3.15

glycolate + acceptor = glyoxylate + reduced acceptor

741109

1.1.5.14

D-fructose + acceptor = 5-dehydro-D-fructose + reduced acceptor

348283, 710853, 739769, 740365, 739767, 740362, 740361, 740364

1.1.5.3

sn-glycerol 3-phosphate + acceptor = glycerone phosphate + reduced acceptor

287831, 287807

1.1.5.4

(S)-malate + acceptor = oxaloacetate + reduced acceptor

Ligand acceptor

Basic Ligand Information

Related pathways

Roles as Enzyme Ligand

In Vivo Substrate in Enzyme-catalyzed Reactions (204 results)

In Vivo Product in Enzyme-catalyzed Reactions (154 results)

Substrate in Enzyme-catalyzed Reactions (954 results)

Product in Enzyme-catalyzed Reactions (338 results)

Inhibitor in Enzyme-catalyzed Reactions (2 results)

Enzyme Kinetic Parameters

References & Links

Literature References (1145)

Links to other databases for acceptor